SCHEMBL5824974

SCHEMBL5824974

COc1cc2ncnc(Oc3ccc(NC(=S)NCCCN4CCCCC4C)cc3)c2cc1OC

nearest known ligand 0.68

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 6/20 0.68
KIT P10721 6/20 0.68
KDR P35968 11/20 0.55
PDGFRB P09619 4/20 0.54
FLT3 P36888 4/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53
CYP2C19 P33261 1/20 0.53
FLT4 P35916 5/20 0.50
CSF1R P07333 2/20 0.49
FLT1 P17948 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5824477 0.89 PDGFRA (0.66) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825920 0.85 PDGFRA (0.68) PDGFRAKITKDRFLT4CSF1R
SCHEMBL5824576 0.85 PDGFRA (0.63) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825567 0.84 PDGFRA (0.70) PDGFRAKITKDRFLT4CSF1R
SCHEMBL5824667 0.83 PDGFRA (0.62) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825695 0.83 PDGFRA (0.61) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825934 0.79 PDGFRA (0.70) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825392 0.79 PDGFRA (0.66) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825187 0.78 PDGFRA (0.67) PDGFRAKITKDRPDGFRBFLT3
SCHEMBL5825272 0.78 PDGFRA (0.70) PDGFRAKITKDRPDGFRBFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 401/4885KDR 4/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA PDGFRA 1/4885KIT 499/4885KDR 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.